Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe diffuse interstitial pneumonitis induced by carmustine (BCNU)

H Lena1, B Desrues, A Le Coz

  • 1Department of Pneumology, Hôpital Pontchaillou-Centre Hospitalier Universitaire de Rennes, France.

Chest
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis.

ESMO open·2025
Same author

[Durable Benefit from Immunotherapy in Advanced NSCLC: The BREATH Cohort].

Revue des maladies respiratoires·2025
Same author

Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer.

Scientific reports·2023
Same author

Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer.

Lung cancer (Amsterdam, Netherlands)·2021
Same author

[Lung metastases of pancreatic adenocarcinoma: Watch for the second train!]

Revue des maladies respiratoires·2019
Same author

[Hypersensitivity pneumonitis presenting as acute respiratory distress syndrome].

Revue des maladies respiratoires·2019
Same journal

The effect of a two-day stay at high altitude (2500 m) on right ventricular afterload and oxygen delivery in patients with pulmonary vascular disease A randomized controlled crossover trial.

Chest·2026
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
See all related articles

A patient developed fatal acute interstitial pneumonitis after carmustine (BCNU) treatment for a brain tumor. Bronchoalveolar lavage suggested an immunoallergic reaction, not a direct toxic effect, as the cause.

Area of Science:

  • Oncology
  • Pulmonology
  • Immunology

Background:

  • Carmustine (BCNU) is a chemotherapy agent used for brain tumors.
  • Acute interstitial pneumonitis is a rare but serious lung complication.
  • The exact mechanism of BCNU-induced pneumonitis is debated, with toxic and immunoallergic hypotheses.

Observation:

  • A patient treated with carmustine for a brain tumor developed fatal acute interstitial pneumonitis.
  • Bronchoalveolar lavage (BAL) was performed to investigate the lung condition.

Findings:

  • BAL analysis revealed lymphocyte alveolitis.
  • A low CD4/CD8 ratio (0.36) was observed in the BAL fluid.
  • This finding supports an immunoallergic mechanism over a direct toxic effect.

Related Experiment Videos

Implications:

  • The findings suggest that carmustine-induced pneumonitis may be an immune-mediated adverse reaction.
  • This highlights the importance of considering immunoallergic mechanisms in drug-induced lung injury.
  • Further research into the immunopathogenesis of BCNU pneumonitis is warranted.